ANIK Anika Therapeutics PE ratio, current and historical analysis
The current P/E ratio of ANIK can't be determined, as the TTM EPS of -$6.65 is negative. The most recent PE ratio recorded for Anika Therapeutics was 123.55 in December 2021.
ANIK PE ratio history
Over the last ten years, the average PE ratio of Anika Therapeutics has been 27.61. In the past ten years, ANIK's PE ratio reached its highest point in the Dec 2021 quarter at 123.55, with a price of $35.83 and an EPS of $0.29. The Mar 2020 quarter saw the lowest point at 14.31, with a price of $28.91 and an EPS of $2.02.
Anika Therapeutics PE ratio by year
Maximum annual increase: 19.06% in 2016
Maximum annual decrease: -40.28% in 2014
| Year | PE ratio | Change |
|---|---|---|
| 2023 | N/A | N/A |
| 2022 | N/A | N/A |
| 2021 | 123.55 | N/A |
| 2020 | N/A | N/A |
| 2019 | 26.87 | 3.95% |
| 2018 | 25.85 | 4.53% |
| 2017 | 24.73 | 12.15% |
| 2016 | 22.05 | 19.06% |
| 2015 | 18.52 | 18.64% |
| 2014 | 15.61 | -40.28% |
ANIK average PE ratio chart
ANIK PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| HALO Halozyme Therapeutics Inc | 14.89 | $5.81B |
| JNJ Johnson & Johnson | 25.79 | $374.39B |
| MDT Medtronic plc | 28.44 | $108.68B |
| SYK Stryker Corp | 41.37 | $148.73B |
| STAA Staar Surgical Co | 60.52 | $1.31B |
| ANIK Anika Therapeutics Inc | N/A | $255.27M |
Frequently asked questions
What is Anika Therapeutics's PE ratio?
The current price to earnings ratio of ANIK can't be calculated, as its EPS of -$6.65 is negative.
What is the highest PE ratio for ANIK?
The highest quarterly PE ratio in the last ten years has been 123.55 and it was in the Dec 2021 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.